# Hologic, Inc. – Consensus ‘buy’ rating and 24.4% Upside Potential

- Link: https://www.directorstalkinterviews.com/hologic-inc.consensus-buy-rating-and-24.4-upside-potential/4121127928
- Published: 2023-09-20T14:49:51+01:00
- Author: Charlotte Edwards

**Hologic, Inc.** which can be found using ticker (HOLX) have now 13 analysts in
total covering the stock. The consensus rating is pointing to ‘buy’. The range between
the high target price and low target price is between 95 and 80 and has a mean target
at $89.54. Now with the previous closing price of $72.00 and the analysts are correct
then we can expect a percentage increase in value of 24.4%. Also worth taking note
is the 50 day moving average now sits at $76.15 while the 200 day moving average
is $79.17. The company has a market cap of 17.64B. The current share price for the
company is: 72.02 USD

 The potential market cap would be $21,938,198,424 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 36.74, revenue per share of 16.28
and a 6.22% return on assets.

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products,
medical imaging systems, and surgical products focused on women’s health and well-
being through early detection and treatment. The Company operates through four segments:
Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Its Diagnostics segment
offers a range of diagnostics products, such as ThinPrep cytology system, and the
Rapid Fetal Fibronectin Test. Its Breast Health segment offers a portfolio of solutions
for breast cancer care, primarily in the areas of radiology, breast surgery, pathology
and treatment. The GYN Surgical segment offers a range of products, such as NovaSure
Endometrial Ablation System, MyoSure Hysteroscopic Tissue Removal System and Fluent
Fluid Management system as well as its Acessa ProVu laparoscopic radiofrequency 
ablation system. The Skeletal Health segment offers products such as the Horizon
DXA, a dual energy x-ray system, and the Fluoroscan Insight FD mini C-arm.

Share on: